News Channels

19 Sep 2018 Alector Initiates Phase 1 Trial of AL001 for the Treatment of Frontotemporal Dementia
19 Sep 2018 Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
19 Sep 2018 Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies
19 Sep 2018 Agenus Receives Milestone Payment from Incyte
19 Sep 2018 Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
19 Sep 2018 Camurus Announces Positive Topline Phase 3 Results for CAM2038 in Opioid Experienced Patients With Chronic Low-back Pain
19 Sep 2018 CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program
19 Sep 2018 BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round
19 Sep 2018 Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer
19 Sep 2018 GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier
19 Sep 2018 Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol
19 Sep 2018 Sosei Provides Update on HTL0018318
18 Sep 2018 Sun Pharma Announces Receipt of European Commission Approval For ILUMETRI® (tildrakizumab) By Almirall For Treatment Of Moderate-To-Severe Chronic Plaque Psoriasis
18 Sep 2018 Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
18 Sep 2018 European Medicines Agency Validates Bristol-Myers Squibb’s Application for Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone in Patients with Multiple Myeloma
18 Sep 2018 Novo Nordisk announces plans to transform its approach to Research & Development
18 Sep 2018 Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma
18 Sep 2018 Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
18 Sep 2018 GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer
18 Sep 2018 MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top